ASNC/Pfizer Young Investigator in Cardiac Amyloidosis Research Fellowship Award

Gain Funding to Promote Your Research

The ASNC/Pfizer Young Investigator in Cardiac Amyloidosis Research Fellowship Award provides $25,000 of support to eligible investigators for a mentored research project exploring the role of nuclear cardiology in the early detection of TTR cardiac amyloidosis.

The recipient will have the distinct honor of presenting the status of their research at the 32nd Annual Scientific Session and Exhibition of the American Society of Nuclear Cardiology, to be held Sept. 2027.

The call for 2026 applications will open September 16, 2026.

Award Info

Goals

Increase opportunities for clinical research focused on cardiac amyloidosis and to improve early diagnosis, timely referral to amyloid experts, and knowledge of emerging treatment options.
Improve outcomes of patients with ATTR-CM.
Encourage and support careers in nuclear cardiology research while growing the science of cardiac imaging and advancing the specialty.

Objectives

Promote research in nuclear cardiology among young investigators.
Create platform for research projects in the area of advancing early detection of TTR cardiac amyloidosis utilizing nuclear cardiology.
Provide an "initial" grant for young investigators that will serve as a stepping stone to larger awards.
Promote the field of nuclear cardiology by supporting new and innovative research.

Award Amount/Project Duration

$25,000 for one year

Number of Awards

One (1)

Application Deadline

November 30, 2026

Award Eligibility

Individuals who:

Hold an MD, PhD or equivalent degree
Are post-doctoral fellows or faculty in the first three years of appointment on the date of the application deadline
Intend to pursue an academic career in nuclear cardiology
Have an active ASNC membership

Individuals with prior independent investigator awards (e.g., NIH, R0l) will not be eligible to apply for this funding. The applicant may not have current overlapping funding from another organization to supplement their proposed work.

Judging Criteria

Applications will be reviewed against the following criteria:

Scientific merit (significance) with focus on the potential for the project to generate data for a successful peer-reviewed grant application
Approach/methods
Innovation and role in early detection or monitoring of TTR cardiac amyloidosis
Investigator qualifications with focus on the potential for the principal investigator to develop into an independent investigator
Quality of mentor and training environment – letter of reference from mentor
Research benefit for the field of nuclear cardiology

A rating scale such as the one below will be utilized by the award committee for scoring each application. A numerical scoring system from 1.0 to 5.0 -- 1.0 is highest; 2.5 is mid-range; 5.0 is lowest.